Literature DB >> 17856

Variable pharmacokinetics of mexiletine.

C M Kaye, M A Kiddie, P Turner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17856

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  [Treatment with mexiletine. Clinical and pharmacokinetic studies].

Authors:  H Breithaupt; A Schmidt
Journal:  Klin Wochenschr       Date:  1988-06-01

Review 2.  Clinical pharmacokinetics of mexiletine.

Authors:  L Labbé; J Turgeon
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

3.  Mexiletine removal by peritoneal dialysis.

Authors:  T E Jones; P A Reece; G C Fisher
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

5.  Enhanced metabolism of mexiletine after phenytoin administration.

Authors:  E J Begg; P M Chinwah; C Webb; R O Day; D N Wade
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 6.  Therapeutic drug monitoring of antiarrhythmic agents.

Authors:  J E Brown; D G Shand
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

7.  The metabolism of mexiletine in relation to the debrisoquine/sparteine-type polymorphism of drug oxidation.

Authors:  F Broly; N Vandamme; C Libersa; M Lhermitte
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

8.  Influence of debrisoquine hydroxylation phenotype on the pharmacokinetics of mexiletine.

Authors:  P Lledó; S M Abrams; A Johnston; M Patel; R M Pearson; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Mexiletine disposition: individual variation in response to urine acidification and alkalinisation.

Authors:  B G Mitchell; J A Clements; A Pottage; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

10.  Cirrhosis of the liver markedly impairs the elimination of mexiletine.

Authors:  P J Pentikäinen; S Hietakorpi; M O Halinen; L M Lampinen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.